Skip to main content
. 2021 May 12;11:524851. doi: 10.3389/fcimb.2021.524851

Figure 2.

Figure 2

Neurogenin 3 immunoreactive cells in patients with irritable bowel syndrome (A) before and (B) after fecal microbiota transplantation.